MTOR and neoplasm: The apoptosis-inducing mTOR inhibitor Torin-1 hindered growth, motility, invasion, and survival of CD326+/CD24+/CD49f+/CD29+ and CD326+/CD44+/CD166+ CRC subpopulations in vitro, and suppressed tumor growth in vivo with a concomitant reduction in vessel formation.